The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
Dit zal plaatsvinden in Lissabon. Meer informatie kunt u vinden op de website.
RT @radboudumc: Meer varianten TLR7 gen gevonden in jonge gezonde mannen met ernstige Covid-19. https://t.co/GI5Tqoz6if
RT @CRavenswaaij: Nice collaboration with our colleagues from #AZP, Academic Hospital Paramaribo Suriname: very educational paper on insuli…
RT @NL_Wetenschap: In de laatste twintig jaar hebben wetenschappers heel veel locaties op het DNA gevonden die de kans op ziektes en andere…